Poordad, Fred <br/><br/>
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis.  [electronic resource] 

 -  Journal of hepatology  10 2017 
 - 700-707 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2017.06.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anilides--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Female<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Lactams, Macrocyclic<br/>Liver Cirrhosis--drug therapy<br/>Macrocyclic Compounds--administration & dosage<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Ribavirin--administration & dosage<br/>Ritonavir--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Sustained Virologic Response<br/>Uracil--administration & dosage<br/>Valine<br/>Young Adult